Analysts expect 60 Degrees Pharmaceuticals, Inc. to report revenue of 280,068.30 for Q3 26, against a range of 267,214.01 to 292,922.59. The most recent reported quarter, Q2 26, came in at 207,900.00, a 16.4% beat against the 178,670.22 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 135,000.00 | 230,000.00 | 163,600.00 | 305,000.00 | 500,000.00 | 310,000.00 | 230,000.00 | 207,900.00 | - | - | - | - | - | - | - | - | ||||||
| High Estimate | 254,320.54 | 269,400.59 | 331,739.07 | 335,982.02 | 217,650.71 | 363,187.91 | 436,310.05 | 187,566.03 | 292,922.59 | 337,560.24 | 412,389.99 | 569,470.16 | 615,633.78 | 566,096.33 | 369,071.52 | 488,437.27 | ||||||
| Low Estimate | 213,576.96 | 248,449.41 | 303,222.93 | 278,849.98 | 203,589.29 | 315,154.49 | 401,713.11 | 169,774.41 | 267,214.01 | 296,476.56 | 356,422.01 | 500,069.84 | 530,310.22 | 482,637.07 | 304,832.32 | 415,027.17 | ||||||
| Consensus Estimate | 233,948.75 | 258,925.00 | 317,481.00 | 307,416.00 | 210,620.00 | 339,171.20 | 419,011.58 | 178,670.22 | 280,068.30 | 317,018.40 | 384,406.00 | 534,770.00 | 572,972.00 | 524,366.70 | 336,951.92 | 451,732.22 |
Analysts expect 60 Degrees Pharmaceuticals, Inc. to report earnings per share of -0.58 for Q3 26, against a range of -0.61 to -0.55. The most recent reported quarter, Q2 26, came in at -0.90, a 15.4% miss against the -0.78 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -18.60 | -9.18 | -6.24 | -4.82 | -2.67 | -1.69 | -1.28 | -0.90 | - | - | - | - | - | - | - | - | ||||||
| High Estimate | -12.37 | -14.03 | -4.98 | -4.41 | -1.61 | -1.33 | -0.68 | -0.74 | -0.55 | -0.61 | -0.81 | -0.87 | 1.69 | 2.45 | -1.55 | -2.11 | ||||||
| Low Estimate | -14.01 | -15.85 | -5.76 | -5.05 | -1.85 | -1.43 | -0.80 | -0.82 | -0.61 | -0.67 | -0.91 | -0.95 | 1.43 | 2.19 | -1.69 | -2.45 | ||||||
| Consensus Estimate | -13.19 | -14.94 | -5.37 | -4.73 | -1.73 | -1.38 | -0.74 | -0.78 | -0.58 | -0.64 | -0.86 | -0.91 | 1.56 | 2.32 | -1.62 | -2.28 |